- Home
- AGAE vs SER Comparison
AGAE vs SER Comparison
Compare AGAE & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGAE
- SER
- Stock Information
- Founded
- AGAE 2017
- SER 2017
- Country
- AGAE United States
- SER United States
- Employees
- AGAE N/A
- SER N/A
- Industry
- AGAE Cable & Other Pay Television Services
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- AGAE Telecommunications
- SER Health Care
- Exchange
- AGAE Nasdaq
- SER Nasdaq
- Market Cap
- AGAE 47.2M
- SER 47.5M
- IPO Year
- AGAE N/A
- SER 2018
- Fundamental
- Price
- AGAE $1.12
- SER $4.11
- Analyst Decision
- AGAE
- SER Strong Buy
- Analyst Count
- AGAE 0
- SER 1
- Target Price
- AGAE N/A
- SER $11.00
- AVG Volume (30 Days)
- AGAE 21.9K
- SER 10.0K
- Earning Date
- AGAE 03-26-2025
- SER 11-12-2024
- Dividend Yield
- AGAE N/A
- SER N/A
- EPS Growth
- AGAE N/A
- SER N/A
- EPS
- AGAE N/A
- SER N/A
- Revenue
- AGAE $9,256,023.00
- SER $3,157,500.00
- Revenue This Year
- AGAE N/A
- SER N/A
- Revenue Next Year
- AGAE N/A
- SER N/A
- P/E Ratio
- AGAE N/A
- SER N/A
- Revenue Growth
- AGAE 36.15
- SER 2454.55
- 52 Week Low
- AGAE $0.61
- SER $3.81
- 52 Week High
- AGAE $1.57
- SER $22.32
- Technical
- Relative Strength Index (RSI)
- AGAE 61.30
- SER 32.61
- Support Level
- AGAE $1.00
- SER $4.66
- Resistance Level
- AGAE $1.10
- SER $4.87
- Average True Range (ATR)
- AGAE 0.06
- SER 0.20
- MACD
- AGAE 0.00
- SER -0.05
- Stochastic Oscillator
- AGAE 82.95
- SER 1.14
About AGAE Allied Gaming & Entertainment Inc.
Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.